The mother of all bear markets in equities is dead: Shankar Sharma

The mother of all bear markets in equities is dead: Shankar Sharma



Developments in West Asia have triggered a panic-like situation across global equity markets. Puneet Wadhwa caught up with SHANKAR SHARMA, founder, GQuant Investech in New Delhi on his interpretation of the developments. Investor’s focus on China, he believes, can spoil the Indian equity market party. Edited excerpts:


A war, you had recently said, has the potential to trigger a bear market in equities. Do the recent developments in West Asia have that potential?

Click here to connect with us on WhatsApp


Well, a nuclear war can surely put equities in a bear phase. I don’t think that the current developments in West Asia can. The mother of all bear markets in equities is dead, only the children are alive, which do not have the potential to put equities in bear territory. There can be small disruptions, which can at best trigger a small correction in regular intervals.

 


We have mastered the art of neutering the ‘bear market villains’ – speculation, inflation, war, disease – we have dealt with them all. In short, we can deal with Pran, Prem Chopra, Gulshan Grover, Do. No. etc. The hero (bull market) always triumphs in the end.


What’s your reading about China now in the backdrop of all the stimulus measures? Can China spoil the Indian equity party?


It can do so, and there are no two ways about it. In the last 2 – 3 years, there was no challenger to the Indian equities in the Asian / emerging market (EM) context. Now, we have Chinese markets. One must realize that China is no small market. In the backdrop of the stimulus measures, it has added nearly $3 trillion to its market capitalisation, which is a significant portion when compared to the total size of the Indian equity markets. And, they have added that in just one rally! It is a giant market and will make investors consider China, which was not the case 2 – 3 years ago. The needle is no longer aligned only towards India now.


So, what will make Indian equities get back their mojo?


I am not saying that the Indian equities are completely out of reckoning. They will remain important and the mojo is not completely lost.


Can the fall seen in the Indian equities in the last few sessions due to developments in West Asia prolong further?


I don’t think that the world will allow the tensions in West Asia to escalate further. There is too much risk involved and there is too much at stake. It is better to call off the game now. The fall in equity markets is a temporary phase. That said, the problems with Gaza are very much there and there has to be a solution to it.


For investors, valuations of the Indian markets till now were a deterrent. Has the fall made the Indian markets juicy enough now for foreign investors to put in money?


The Indian markets have not fallen enough to correct valuations. The fall has just been around 2 – 3 per cent. The markets were trading at around 22x forward earnings, which are in no means cheap. Indian markets will cool-off more in the immediate future as China hogs the limelight. I don’t see the runaway madness in Indian equity markets that we saw in the last few years. That said, we will not see a bear market, but a cyclical slowdown. A bear phase is ruled out.


So, a flash correction then?


Precisely. A bear market is when a stock or an index slips 20 per cent or more. Now-a-days, the fall is sharp and the pull back is swift. Done and dusted in a matter of just 4 – 5 days. In a nutshell, I don’t see a threat to the Indian equity markets, but a slowdown.


Retail investors seem to have found a new playground – the primary markets. Are the primary markets now a threat in terms of liquidity to the (once) thriving small-and mid-cap segments we had in the secondary market?


Well, there are a lot of crazy companies with no or insignificant fundamentals and crazy valuations often hitting the primary markets. We have seen this earlier as well. I did so in 1996, and things ended badly. But a lot of investors have matured since then in the way they invest.


Talking about 1996, you were one of the first research houses that spotted HDFC Bank and recommended a ‘buy’ on their initial public offering (IPO). Do you find any companies that are hitting the primary market now that have similar potential?


HDFC Bank is a different kettle. It was a par or a near-par issue. Most IPOs these days come in with a significant premium and/or leave nothing much on the table for the investors. We did not have free pricing back then as we do today. A company that is good will come in at a significant premium. This limits future gains. An IPO like HDFC Bank is like hoping for another Sholay from Ramesh Sippy.

First Published: Oct 04 2024 | 2:51 PM IST



Source link

Visa unveils platform for global banks to issue stablecoin, other tokens

Visa unveils platform for global banks to issue stablecoin, other tokens



Visa Inc. has launched a new platform to help banks issue stablecoins and other fiat-backed tokens internationally. The Visa Tokenized Asset Platform (VTAP) will go live next year.


 

Click here to connect with us on WhatsApp


VTAP will enable banks to “mint, burn and transfer” tokens, providing a robust infrastructure for financial institutions looking to leverage the benefits of blockchain technology, said a statement. The service is being launched as more businesses and financial institutions express growing interest in how cryptocurrencies and blockchain can enhance their operations.


 


“Visa has been at the forefront of digital payments for nearly sixty years, and with the introduction of VTAP, we are once again setting the pace for the industry,” said Vanessa Colella, global head of innovation and digital partnerships at Visa, in the statement.

 


 


“We’re excited to leverage our experience with tokenization to help banks integrate blockchain technologies into their operations.”


 


Testing phase and future plans


 


Spanish bank BBVA has tested Visa’s platform for a year and expects a pilot for select customers on the Ethereum blockchain at some point next year.


 


Stablecoins are cryptocurrencies typically pegged to stable assets like the US dollar; they have gained significant traction in recent years. They offer a bridge between traditional finance and cryptocurrencies, providing a less volatile option for transactions and a safe haven from the price fluctuations common in cryptocurrencies like Bitcoin and Ether.


 


Visa’s entry into this space follows similar moves by other financial technology giants. PayPal Holdings Inc. has already launched its stablecoin, PYUSD, while Stripe Inc. now allows merchants to accept stablecoins for online transactions.


 


Experts suggest this development could potentially accelerate the adoption of blockchain technology in mainstream finance, offering banks new tools to innovate and expand their services in the digital age. As the lines between traditional banking and cryptocurrency continue to blur, platforms like VTAP may play a crucial role in shaping the future of global finance.

First Published: Oct 04 2024 | 1:39 PM IST



Source link

Indoco Remedies shares rise over 3% on USFDA nod for allergy drug

Indoco Remedies shares rise over 3% on USFDA nod for allergy drug



Mumbai based pharmaceutical company Indoco Remedies share price surged 3.13 per cent at Rs 349.95 per share on the BSE. The stock price jumped after the company on Friday said that it has received  final ANDA approval from the US FDA for Cetirizine Hydrochloride Tablets 10 mg (OTC).


The drug is a generic equivalent of the reference listed drug, Zyrtec Allergy Tablets, 10 mg of Johnson & Johnson Consumer Inc. 

Click here to connect with us on WhatsApp


Cetirizine Hydrochloride Tablets USP, 10 mg will be manufactured by Indoco, at their manufacturing facility located at L-14, Verna Industrial Area, Verna, Goa – 403722 in India, it said in a statement. Cetirizine is used for relief of symptoms of hay fever and other allergic conditions. 

 


“This approval is a testament to Indoco’s commitment to delivering high-quality and affordable healthcare solutions to global markets. We are proud to contribute to providing effective allergy relief medicines and remain focussed in expanding our portfolio in the OTC space,” said Aditi Panandikar, managing director, Indoco Remedies. 


Indoco is a pharmaceutical company with a global presence, generating a turnover of $212 million. The company has a workforce of over 6,000 employees and operates 11 manufacturing facilities—seven for finished dosage forms (FDFs) and four for active pharmaceutical ingredients (APIs)—alongside a R&D centre and a contract research organisation (CRO) facility. 


Indoco develops and manufactures a diverse range of pharmaceutical products for both Indian and international markets, generating over 106 million prescriptions annually from more than 235,000 doctors across various specialties. With eight domestic marketing divisions, Indoco boasts a strong brand portfolio spanning multiple therapeutic areas, including gastro-intestinal, respiratory, anti-infective, ophthalmic, nutritional, cardiovascular, anti-diabetic, pain management, and gynaecology


Share price history


Indoco Remedies share price underperformed the market as it plummeted 13.1 per cent year to date, while gaining only 2 per cent in the last one year. In comparison BSE Sensex has risen 14.6 per cent year to date and 27 per cent in a year.


The company has a total market capitalization of Rs 3,125.90 crore. Its shares are trading at price to earnings valuation of 29.60 times, while having an earning per share of Rs 11.46.


At 1:30 PM, the stock price of the company pared all its gains, and slipped in red by 0.06 per cent at Rs 339.10 a piece on the BSE. By comparison, the BSE’s Sensex was up 0.64 per cent to 81,973.11 level. 

First Published: Oct 04 2024 | 1:35 PM IST



Source link

Reliance Power hits 5% lower circuit as board okays 0 mn fundraise

Reliance Power hits 5% lower circuit as board okays $500 mn fundraise


Urban electrification remains but a glimmer of its full potential


Reliance Power’s share price was locked in 5 per cent lower circuit at Rs Rs 40.06 a piece on the BSE. The decline was followed by the company’s announcement to raise funds from affiliates of US based Värde Investment Partners. 


The company’s board of directors has approved a fundraise of $500 million (approximately Rs 4,200 crore) through the issuance of foreign currency convertible bonds (FCCBs). These bonds will be offered on a private placement basis to a US company, featuring a low interest rate of 5 per cent per annum and a tenure of 10 years. The FCCBs are unsecured in nature, the company said in an exchange filing on Thursday.

Click here to connect with us on WhatsApp

 


The FCCBs will be convertible into approximately 82.30 crore equity shares at a nominal value of Rs 10 each, with a conversion price set at Rs 51 per share, which includes a premium of Rs 41. The allotment of these FCCBs is expected to occur within 30 days from the issue closing date. The total issuance will consist of up to 500 FCCBs, each valued at $1,000,000, aggregating to a total of $500,000,000.


The unlisted FCCBs will have a tenure of 10 years and 1 day from the date they are fully paid up, offering a low interest rate of 5 per cent per annum.


Earlier on September 24, 2024, the company’s boards also gave nod for a fundraiser of Rs 1,524.60 crore through a preferential issue of up to 46.20 crore equity shares, priced at Rs 33 each. Reliance Infrastructure Limited, the company’s promoter, aims to increase its equity stake by over Rs 600 crore. Other notable investors participating in this preferential issue include Authum Investment and Infrastructure Limited and Sanatan Financial Advisory Services Private Limited.


The funds raised through this issue will be allocated towards business expansion, investments in subsidiaries and joint ventures, debt reduction, and general corporate purposes, the company had disclosed previously.  


In its latest financial report for the quarter ended June 30, 2024 (Q1FY25), Reliance Power narrowed its consolidated net loss to Rs 97.85 crore, significantly improved from the Rs 296.3 crore loss recorded in the same quarter last year. This reduction in losses was attributed to increased revenue and reduced expenses, with total revenue rising by 6 per cent to Rs 2,069.1 crore, largely driven by an uptick in other income.


Currently, Reliance Power shares trade at a price-to-earnings (P/E) ratio of 316.18, with an earnings per share (EPS) of Rs 0.17. The company’s stock has experienced a 52-week range, with the highest price at Rs 54.25 and the lowest at Rs 15.53.


Established as Reliance Energy Generation Limited, Reliance Power is a key player in the Reliance Anil Dhirubhai Ambani Group, focusing on developing, constructing, operating, and maintaining power projects both in India and internationally.

First Published: Oct 04 2024 | 12:22 PM IST



Source link

Angel One shares slip over 4% as average daily order fall in Sept quarter: Angel one share price

Angel One shares slip over 4% as average daily order fall in Sept quarter: Angel one share price


Angel One’s ADO declined 2.8 per cent M-o-M to 7.46 million in September 2024


Angel One shares slipped 4.3 per cent and registered an intraday low of Rs 2,620 per share on the BSE. The scrip declined after the discount broking firm’s business update showed a dip in average daily orders (ADO) on a month-on-month (M-o-M) and quarter-on-quarter (Q-o-Q) basis.

At around 10:05 AM, Angel One share price was down 2 per cent at Rs 2,684.8 per share on the BSE. In comparison, the BSE Sensex traded 0.05 per cent higher at 82,534.31 around the same time.

Click here to connect with us on WhatsApp


On Friday, Angel One released its business update which showed its average daily orders (ADO) slipped 0.8 per cent to 7.64 million in the quarter ended September 30, 2024, from 7.7 million in the June quarter. However, on a year-on-year (Y-o-Y) basis, the ADO increased 42.3 per cent (Q2FY24 to Q2FY25).

 


Similarly, Angel One’s ADO declined 2.8 per cent M-o-M to 7.46 million in September 2024, from 7.68 million in August 2024. However, ADO grew 29.9 per cent year-on-year (Y-o-Y) (September 2023 to September 2024).


Likewise, its number of orders also dipped 2.8 per cent to 156.68 million in September 2024 as against 161.18 million in August 2024. On a Y-o-Y basis (September 2023 to September 2024), the number of orders increased by 36.3 per cent.  


Angel One’s average daily turnover (ADTO) based on option premium for the F&O segment declined 2.9 per cent M-o-M to Rs 14,700 crore last month from Rs 15,100 crore in August 2024. Its cash daily turnover also declined 4.9 per cent in September 2024 to Rs 9,100 crore from Rs 9,600 crore in August 2024.


However, its overall ADTO based on option premium, including cash segment, notional turnover for equity futures & options, and commodity segments, grew 5.8 per cent on a monthly basis and 56.4 per cent Y-o-Y (September 2023 to September 2024).


On the flip side, Angel One’s client base grew 61 per cent Y-o-Y and 11.2 per cent Q-o-Q to 27.49 million in the quarter ended September 30, 2024, against 17.07 million a year ago.


In the past one year, shares of Angel One have gained 47.3 per cent as against BSE Sensex’s rise of 26.4 per cent.

First Published: Oct 04 2024 | 11:39 AM IST



Source link

M&M Finance shares decline 6% after releasing Q2FY25 business update: M&M Finance share price

M&M Finance shares decline 6% after releasing Q2FY25 business update: M&M Finance share price


M&M finance share price slips after Q2 business update (Representational image)


M&M Finance share price: Mahindra and Mahindra Financial Services shares slipped over 6 per cent on Friday, October 4, and registered an intraday low at Rs 301.55 per share on BSE after the company released its Q2FY25 business update.

At around 9:27 AM, shares of M&M Finance were down 6.24 per cent at Rs 302.05 per share on the BSE. In comparison, the BSE Sensex was trading 0.36 per cent lower at 82,199.57 around the same time.

Click here to connect with us on WhatsApp


In an exchange filing released on Thursday after market hours, M&M Finance had said that it expects the overall disbursement in Q2FY25 to decline 1 per cent year-on-year (Y-o-Y) to Rs 13,160 crore. However, it pegged the H1FY25 disbursement at Rs 25,900 crore, a growth of 2 per cent Y-o-Y.

 


Meanwhile, the company’s business assets are pegged at Rs 1.13 crore, showing a growth of 20 per cent in the September quarter from the year-ago period. Its collection efficiency (CE) is anticipated to remain flat at 96 per cent Y-o-Y for the quarter ended September 30, 2024.


Collection efficiency is a metric that measures how well a company or institution collects its debts and loan repayments.


As per the company’s exchange filing, as of September 30, 2024, Stage 3 delinquency is estimated at 3.8 per cent, compared to 4.3 per cent a year ago, while Stage 2 delinquency is estimated at 6.4 per cent, compared to 5.7 per cent Y-o-Y.


M&M Finance’s liquidity chest for the quarter under review could come to over Rs 8,500 crore, the company added. The company’s board on Thursday also approved the offer and issuance of Non-Convertible Subordinated debentures on a private placement basis.


The issue size is Rs 750 crore and 75,000 debentures will be issued at a face value of Rs 1,00,000, it added.


The tenure of the debenture is nine years and 363 days from October 8, 2024. The fixed coupon rate is set at 8.24 per cent per annum.


In the past one year, shares of M&M Finance have gained 4.2 per cent, compared to the BSE Sensex’s rise of 26.4 per cent during the same period. 

First Published: Oct 04 2024 | 10:26 AM IST



Source link

YouTube
Instagram
WhatsApp